Incidence and mortality of liver cancer in China, 2010.
- Author:
Kuang-Rong WEI
1
;
Xia YU
;
Rong-Shou ZHENG
;
Xia-Biao PENG
;
Si-Wei ZHANG
;
Ming-Fang JI
;
Zhi-Heng LIANG
;
Zhi-Xiong OU
;
Wan-Qing CHEN
Author Information
- Publication Type:Journal Article
- MeSH: China; epidemiology; Female; Humans; Incidence; Liver Neoplasms; epidemiology; mortality; Male; Registries; Rural Population; Sex Distribution; Urban Population
- From:Chinese Journal of Cancer 2014;33(8):388-394
- CountryChina
- Language:English
- Abstract: Liver cancer is a common malignant tumor in China and a major health concern. We aimed to estimate the liver cancer incidence and mortality in China in 2010 using liver cancer data from some Chinese cancer registries and provide reference for liver cancer prevention and treatment. We collected and evaluated the incidence and mortality data of liver cancer in 2010 from 145 cancer registries, which were included in the 2013 Chinese Cancer Registry Annual Report, calculated crude, standardized, and truncated incidences and mortalities, and estimated new liver cancer cases and deaths from liver cancer throughout China and in different regions in 2010 from Chinese practical population. The estimates of new liver cancer cases and deaths were 358,840 and 312,432, respectively, in China in 2010. The crude incidence, age-standardized rate by Chinese standard population (ASR China), and age-standardized rate by world standard population (ASR world) were 27.29/100,000, 21.35/100,000, and 20.87/100,000, respectively; the crude, ASR China, and ASR world mortalities were 23.76/100,000, 18.43/100,000, and 18.04/100,000, respectively. The incidence and mortality were the highest in western regions, higher in rural areas than in urban areas, and higher in males than in females. The age-specific incidence and mortality of liver cancer showed a rapid increase from age 30 and peaked at age 80-84 or 85+. Our results indicated that the 2010 incidence and mortality of liver cancer in China, especially in undeveloped rural areas and western regions, were among high levels worldwide. The strategy for liver cancer prevention and treatment should be strengthened.
